Chinese scientists use supercomputer to cut new drug screening time from years to seconds

Chinese scientists have developed an artificial intelligence platform for drug discovery named GalaxyVS. This platform, powered by China's Tianhe supercomputers, can screen extensive libraries of chemical compounds in mere seconds, drastically reducing the initial drug screening phase from months or years to tens of seconds. The developers anticipate that GalaxyVS will offer a new approach to identifying lead molecules for treating various conditions, including tumors, neurodegenerative diseases, rare diseases, and emerging infectious diseases. The system is also expected to accelerate drug research during public health crises.